139 related articles for article (PubMed ID: 21982487)
1. The metabolic syndrome and risk of prostate cancer in Italy.
Pelucchi C; Serraino D; Negri E; Montella M; Dellanoce C; Talamini R; La Vecchia C
Ann Epidemiol; 2011 Nov; 21(11):835-41. PubMed ID: 21982487
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study.
Montella M; Di Maso M; Crispo A; Grimaldi M; Bosetti C; Turati F; Giudice A; Libra M; Serraino D; La Vecchia C; Tambaro R; Cavalcanti E; Ciliberto G; Polesel J
BMC Cancer; 2015 Oct; 15():720. PubMed ID: 26475132
[TBL] [Abstract][Full Text] [Related]
3. Metabolic disorders and the risk of nasopharyngeal carcinoma: a case-control study in Italy.
Zucchetto A; Taborelli M; Bosetti C; Montella M; La Vecchia C; Franchin G; Libra M; Serraino D; Polesel J
Eur J Cancer Prev; 2018 Mar; 27(2):180-183. PubMed ID: 27479542
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and the risk of prostate cancer in Italy.
Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
[TBL] [Abstract][Full Text] [Related]
6. Hypercholesterolemia and prostate cancer: a hospital-based case-control study.
Magura L; Blanchard R; Hope B; Beal JR; Schwartz GG; Sahmoun AE
Cancer Causes Control; 2008 Dec; 19(10):1259-66. PubMed ID: 18704722
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
8. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
9. Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer.
Bravi F; Scotti L; Bosetti C; Talamini R; Negri E; Montella M; Franceschi S; La Vecchia C
Ann Oncol; 2006 Jun; 17(6):1014-7. PubMed ID: 16611646
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and the risk of prostate cancer.
Tavani A; Gallus S; Bosetti C; Tzonou A; Lagiou P; Negri E; Trichopoulos D; La Vecchia C
Eur J Cancer Prev; 2002 Apr; 11(2):125-8. PubMed ID: 11984129
[TBL] [Abstract][Full Text] [Related]
11. The impact of diabetes and other metabolic disorders on prostate cancer prognosis.
Polesel J; Gini A; Dal Maso L; Stocco C; Birri S; Taborelli M; Serraino D; Zucchetto A
J Diabetes Complications; 2016; 30(4):591-6. PubMed ID: 26936307
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and hepatocellular carcinoma risk.
Turati F; Talamini R; Pelucchi C; Polesel J; Franceschi S; Crispo A; Izzo F; La Vecchia C; Boffetta P; Montella M
Br J Cancer; 2013 Jan; 108(1):222-8. PubMed ID: 23169288
[TBL] [Abstract][Full Text] [Related]
13. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in risk of prostate cancer associated with metabolic syndrome.
Beebe-Dimmer JL; Nock NL; Neslund-Dudas C; Rundle A; Bock CH; Tang D; Jankowski M; Rybicki BA
Urology; 2009 Jul; 74(1):185-90. PubMed ID: 19428088
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome and Prostate Cancer Risk: A Population Case-control Study.
Hernández-Pérez JG; Torres-Sánchez L; Hernández-Alcaráz C; López-Carrillo L; Rodríguez-Covarrubias F; Vázquez-Salas RA; Galván-Portillo M
Arch Med Res; 2022 Sep; 53(6):594-602. PubMed ID: 35909002
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study.
Agnoli C; Berrino F; Abagnato CA; Muti P; Panico S; Crosignani P; Krogh V
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):41-8. PubMed ID: 19361966
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis.
Rosato V; Tavani A; Bosetti C; Pelucchi C; Talamini R; Polesel J; Serraino D; Negri E; La Vecchia C
Metabolism; 2011 Oct; 60(10):1372-8. PubMed ID: 21550085
[TBL] [Abstract][Full Text] [Related]
18. Features of the metabolic syndrome and prostate cancer in African-American men.
Beebe-Dimmer JL; Dunn RL; Sarma AV; Montie JE; Cooney KA
Cancer; 2007 Mar; 109(5):875-81. PubMed ID: 17265528
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
[TBL] [Abstract][Full Text] [Related]
20. Dietary zinc and prostate cancer risk: a case-control study from Italy.
Gallus S; Foschi R; Negri E; Talamini R; Franceschi S; Montella M; Ramazzotti V; Tavani A; Dal Maso L; La Vecchia C
Eur Urol; 2007 Oct; 52(4):1052-6. PubMed ID: 17292532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
